1.Comparision of the Limberg flap with the V-Y flap technique in the treatment of pilonidal disease.
Fatih ALTINTOPRAK ; Enis DIKICIER ; Yusuf ARSLAN ; Taner OZKECECI ; Gokhan AKBULUT ; Osman Nuri DILEK
Journal of the Korean Surgical Society 2013;85(2):63-67
PURPOSE: In this study, we investigated whether there is a factor that can aid determi nation of the preferred technique by comparing the early and late results of two different surgical techniques for the treatment of pilonidal sinus. METHODS: The medical records of 176 patients in whom the Limberg flap (LF) or V-Y flap techniques were applied for reconstruction after the excision were evaluated retrospectively. RESULTS: The development rates of postoperative hematoma, wound separation, wound infection, and seroma were 2.8%, 5.1%, 5.6%, and 6.3%, respectively, while total flap necrosis was not observed in any patient. Return to daily activities was achieved after a mean of 17.1 days (13 to 21 days) days in the LF group and 32.7 days (18 to 47 days) in the V-Y flap group. During the average follow-up of 65 months (36 to 110 months), nine patients (5.1%) developed recurrent disease. There was no difference between the two groups with respect to early surgical complications (P = 0.286) or disease recurrence (P = 0.094), whereas the resumption of daily activities was longer in patients with a V-Y flap (P < 0.001). CONCLUSION: The early postoperative and long-term results of the LF and V-Y flap techniques for the treatment of pilonidal sinus were similar. Because the resumption of daily activities at work is achieved later in patients undergoing the V-Y flap compared with the LF technique, patients' employment (or position in working life) must be considered when determining the most appropriate surgical technique.
Employment
;
Follow-Up Studies
;
Hematoma
;
Humans
;
Medical Records
;
Necrosis
;
Pilonidal Sinus
;
Recurrence
;
Seroma
;
Wound Infection
2.Evaluation of Overactive Bladder in Male Antidepressant Users: A Prospective Study.
Volkan SOLMAZ ; Sebahattin ALBAYRAK ; Arslan TEKATAS ; Dürdane AKSOY ; Yusuf GENÇTEN ; Sema İNANIR ; Fikret ERDEMIR
International Neurourology Journal 2017;21(1):62-67
PURPOSE: In this study, we investigated overactive bladder (OAB) functions in male patients who used antidepressant drugs (ADs) that were previously examined in female patients, based on conflicting data in literature regarding the effects of AD on OAB and the differences between male and female urinary system physiologies (anatomical and hormonal). METHODS: The study included 202 male patients (a control group of 90 healthy subjects, and an experimental group of 112 patients taking ADs for different disorders). All the patients completed the overactive bladder-validated 8 (OAB-V8) questionnaire, the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), and the Beck Depression Inventory (BDS). RESULTS: The OAB-V8, ICIQ-SF, and BDS scores for the antidepressant users were significantly higher than those of the control group. The highest prevalence of OAB symptoms was observed in patients taking venlafaxine (68.2%), and the lowest prevalence was in patients taking sertraline (28.0%). Moreover, the frequency of OAB between the antidepressant groups was statistically significant. The univariate logistic regression analyses showed a significant relationship between the presence of OAB, antidepressant usage, BDS score, and the age of a patient. In the multivariate logistic regression analyses, the association between the presence of OAB and antidepressant usage was statistically significant. CONCLUSIONS: The present study showed that the incidence of OAB and the severity of OAB symptoms increased in males using antidepressants for various disorders. This may have been due to unique pharmacological effects, on a molecular or individual level, of serotonin-norepinephrine reuptake inhibitors.
Antidepressive Agents
;
Depression
;
Female
;
Healthy Volunteers
;
Humans
;
Incidence
;
Logistic Models
;
Male*
;
Prevalence
;
Prospective Studies*
;
Sertraline
;
Urinary Bladder, Overactive*
;
Venlafaxine Hydrochloride
3.Protective Effect of All-Trans Retinoic Acid in Cisplatin-Induced Testicular Damage in Rats
Cem YUCEL ; Fatma Demet ARSLAN ; Sumeyye EKMEKCI ; Volkan ULKER ; Erdem KISA ; Elcin ERDOGAN YUCEL ; Murat UCAR ; Yusuf Ozlem ILBEY ; Orcun CELIK ; Banu Isbilen BASOK ; Zafer KOZACIOGLU
The World Journal of Men's Health 2019;37(2):249-256
PURPOSE: To investigate the effects of all-trans retinoic acid (ATRA) in cisplatin (CP)-induced testicular damage in rats. MATERIALS AND METHODS: Twenty-eight male Wistar rats were divided into four groups: Control, ATRA alone, ATRA+CP, and CP alone. Body weight, testicular weight, sperm count, sperm motility, percentage of abnormal sperm, total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) in testicular tissue, and testicular histopathology were compared among groups. RESULTS: The sperm count and motility significantly decreased and the percentage of abnormal sperm significantly increased in the CP group compared to the control and ATRA groups. CP+ATRA administration significantly increased the sperm count and motility, but reduced the abnormal sperm count. CP administration significantly increased TOS and OSI compared to the control group and the other groups. Administering CP+ATRA significantly decreased TOS and the OSI in testicular tissue and reduced spermatogenesis, but increased the Johnsen score. CONCLUSIONS: The destructive effects of CP treatment on testicular tissue and spermatogenesis were reduced by administering ATRA.
Animals
;
Body Weight
;
Cisplatin
;
Humans
;
Male
;
Oxidative Stress
;
Rats
;
Rats, Wistar
;
Sperm Count
;
Sperm Motility
;
Spermatogenesis
;
Spermatozoa
;
Testis
;
Tretinoin
;
Vitamin A
4.The effect of adenosine triphosphate on propofol-induced myopathy in rats: a biochemical and histopathological evaluation
Kezban Tuna Ozkaloglu ERDEM ; Zehra BEDIR ; Irem ATES ; Ufuk KUYRUKLUYILDIZ ; Taha Abdulkadir COBAN ; Gulce Naz YAZICI ; Yusuf Kemal ARSLAN ; Zeynep SULEYMAN ; Halis SULEYMAN
The Korean Journal of Physiology and Pharmacology 2021;25(1):69-77
Propofol infusion syndrome characterized by rhabdomyolysis, metabolic acidosis, kidney, and heart failure has been reported in long-term propofol use for sedation. It has been reported that intracellular adenosine triphosphate (ATP) is reduced in rhabdomyolysis. The study aims to investigate the protective effect of ATP against possible skeletal muscle damage of propofol in albino Wistar male rats biochemically and histopathologically. PA-50 (n = 6) and PA-100 (n = 6) groups of animals was injected intraperitoneally to 4 mg/kg ATP. An equal volume (0.5 ml) of distilled water was administered intraperitoneally to the P-50, P-100, and HG groups.One hour after the administration of ATP and distilled water, 50 mg/kg propofol was injected intraperitoneally to the P-50 and PA-50 groups. This procedure was repeated once a day for 30 days. The dose of 100 mg/kg propofol was injected intraperitoneally to the P-100 and PA-100 groups. This procedure was performed three times with an interval of 1 days. Our experimental results showed that propofol increased serum CK, CK-MB, creatinine, BUN, TP I, ALT, AST levels, and muscle tissue MDA levels at 100 mg/kg compared to 50 mg/kg and decreased tGSH levels. At a dose of 100 mg/ kg, propofol caused more severe histopathological damage compared to 50 mg/ kg. It was found that ATP prevented propofol-induced muscle damage and organ dysfunction at a dose of 50 mg/kg at a higher level compared to 100 mg/kg. ATP may be useful in the treatment of propofol-induced rhabdomyolysis and multiple organ damage.
5.The effect of adenosine triphosphate on propofol-induced myopathy in rats: a biochemical and histopathological evaluation
Kezban Tuna Ozkaloglu ERDEM ; Zehra BEDIR ; Irem ATES ; Ufuk KUYRUKLUYILDIZ ; Taha Abdulkadir COBAN ; Gulce Naz YAZICI ; Yusuf Kemal ARSLAN ; Zeynep SULEYMAN ; Halis SULEYMAN
The Korean Journal of Physiology and Pharmacology 2021;25(1):69-77
Propofol infusion syndrome characterized by rhabdomyolysis, metabolic acidosis, kidney, and heart failure has been reported in long-term propofol use for sedation. It has been reported that intracellular adenosine triphosphate (ATP) is reduced in rhabdomyolysis. The study aims to investigate the protective effect of ATP against possible skeletal muscle damage of propofol in albino Wistar male rats biochemically and histopathologically. PA-50 (n = 6) and PA-100 (n = 6) groups of animals was injected intraperitoneally to 4 mg/kg ATP. An equal volume (0.5 ml) of distilled water was administered intraperitoneally to the P-50, P-100, and HG groups.One hour after the administration of ATP and distilled water, 50 mg/kg propofol was injected intraperitoneally to the P-50 and PA-50 groups. This procedure was repeated once a day for 30 days. The dose of 100 mg/kg propofol was injected intraperitoneally to the P-100 and PA-100 groups. This procedure was performed three times with an interval of 1 days. Our experimental results showed that propofol increased serum CK, CK-MB, creatinine, BUN, TP I, ALT, AST levels, and muscle tissue MDA levels at 100 mg/kg compared to 50 mg/kg and decreased tGSH levels. At a dose of 100 mg/ kg, propofol caused more severe histopathological damage compared to 50 mg/ kg. It was found that ATP prevented propofol-induced muscle damage and organ dysfunction at a dose of 50 mg/kg at a higher level compared to 100 mg/kg. ATP may be useful in the treatment of propofol-induced rhabdomyolysis and multiple organ damage.